Helicobacter pylori infection
Conditions
Interventions
experimental group A:Bacillus coagulans tablet
experimental group B:Clostridium butyricum capsules
experimental group C:Bacillus coagulans powder
experimental group D:Clostridium butyricum capsules and Bacillus coagulans tablet
experimental group E:Clostridium butyricum capsules and Bacillus coagulans powder
Sponsors
Nanfang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: The patient must meet the following two requirements: 1. Aged >= 18, <= 70 years, both male and female; 2. Patients with positive C13 urea breath test or rapid urease test.
Exclusion criteria
Exclusion criteria: 1. Patients who have used antibiotics, proton pump inhibitors, bismuth agents, probiotics, hormone drugs or non steroidal anti-inflammatory drugs within one month; 2. Patients with gastroduodenal ulcer, hemorrhage, atrophic gastritis, intestinal metaplasia, early or advanced malignant tumor, etc; 3. Pregnancy or lactation; 4. Patients with serious underlying diseases or other diseases that may lead to ineffective treatment; 5. Patients with history of gastrointestinal surgery or other types of recent surgery; 6. Patients with family genetic history, mental disease history, etc; 7. Patients who are participating in other research projects; 8. The patients who are judged by the researcher to be unsuitable to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse events; | — |
Countries
China
Contacts
Public ContactYang Bai
Nanfang Hospital of Southern Medical University
Outcome results
None listed